In vitro Studies of Non-Diphtheriae Corynebacterium Isolates on Antimicrobial Susceptibilities, Drug Resistance Mechanisms, and Biofilm Formation Capabilities

References

• Ripabelli G, Salzo A, Mariano A, et al. Healthcare-associated infections point prevalence survey and antimicrobials use in acute care hospitals (PPS 2016-2017) and long-term care facilities (HALT-3): a comprehensive report of the first experience in Molise Region, Central Italy, and targeted intervention strategies. J Infect Public Health. 2019;12(4):509–515. doi:10.1016/j.jiph.2019.01.060
   PubMed Web of Science ®Google Scholar
• Kline KA, Lewis AL, Mulvey MA, Stapleton AE, Klumpp DJ. Gram-positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract. Microbiol Spectr. 2016;4(2). doi:10.1128/microbiolspec.UTI-0012-2012
   PubMed Web of Science ®Google Scholar
• Gomila A, Carratala J, Eliakim-Raz N, et al. Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study. Antimicrob Resist Infect Control. 2019;8:198. doi:10.1186/s13756-019-0656-6
   Web of Science ®Google Scholar
• Guzman M, Salazar E, Cordero V, et al. Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela. Biomedica. 2019;39(s1):96–107. doi:10.7705/biomedica.v39i2.4030
   Google Scholar
• Nishikawa JL, Boeszoermenyi A, Vale-Silva LA, et al. Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction. Nature. 2016;530(7591):485–489. doi:10.1038/nature16963
   Web of Science ®Google Scholar
• Petca RC, Negoita S, Mares C, et al. Heterogeneity of antibiotics multidrug-resistance profile of uropathogens in Romanian population. Antibiotics. 2021;10(5):523. doi:10.3390/antibiotics10050523
   Web of Science ®Google Scholar
• Perez-Carrasco V, Soriano-Lerma A, Soriano M, et al. Urinary microbiome: Yin and Yang of the urinary tract. Front Cell Infect Microbiol. 2021;11:617002. doi:10.3389/fcimb.2021.617002
   PubMed Web of Science ®Google Scholar
• Hinic V, Lang C, Weisser M, et al. Corynebacterium tuberculostearicum: a potentially misidentified and multiresistant Corynebacterium species isolated from clinical specimens. J Clin Microbiol. 2012;50(8):2561–2567. doi:10.1128/JCM.00386-12
   PubMed Web of Science ®Google Scholar
• Sengupta M, Naina P, Balaji V, et al. Corynebacterium amycolatum: an unexpected pathogen in the ear. J Clin Diagn Res. 2015;9(12):D1–D3.
   Google Scholar
• Esteban J, Nieto E, Calvo R, et al. Microbiological characterization and clinical significance of Corynebacterium amycolatum strains. Eur J Clin Microbiol Infect Dis. 1999;18(7):518–521. doi:10.1007/s100960050336
   Web of Science ®Google Scholar
• Neugent ML, Hulyalkar NV, Nguyen VH, et al. Advances in understanding the human urinary microbiome and its potential role in urinary tract infection. Mbio. 2020;11(2). doi:10.1128/mBio.00218-20
   Web of Science ®Google Scholar
• Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653–660. doi:10.1038/nrurol.2010.190
   PubMed Web of Science ®Google Scholar
• Neemuchwala A, Soares D, Ravirajan V, et al. In vitro antibiotic susceptibility pattern of non-diphtheriae Corynebacterium isolates in Ontario, Canada, from 2011 to 2016. Antimicrob Agents Chemother. 2018;62(4). e01776–e01817.
   Web of Science ®Google Scholar
• Silva-Santana G, Silva C, Olivella J, et al. Worldwide survey of Corynebacterium striatum increasingly associated with human invasive infections, nosocomial outbreak, and antimicrobial multidrug-resistance, 1976–2020. Arch Microbiol. 2021;203(5):1863–1880.
   Web of Science ®Google Scholar
• Suh JW, Ju Y, Lee CK, et al. Molecular epidemiology and clinical significance of Corynebacterium striatum isolated from clinical specimens</em>. Infect Drug Resist. 2019;12:161–171. doi:10.2147/IDR.S184518
   Web of Science ®Google Scholar
• Dragomirescu CC, Lixandru BE, Coldea IL, et al. Antimicrobial susceptibility testing for Corynebacterium species isolated from clinical samples in Romania. Antibiotics. 2020;9(1):31. doi:10.3390/antibiotics9010031
   Web of Science ®Google Scholar
• Nicolosi D, Genovese C, Cutuli MA, et al. Preliminary in vitro studies on Corynebacterium urealyticum pathogenetic mechanisms, a possible candidate for chronic idiopathic prostatitis? Microorganisms. 2020;8(4):463. doi:10.3390/microorganisms8040463
   Web of Science ®Google Scholar
• Ruiz-Pino M, Foronda-Garcia-Hidalgo C, Alarcon-Blanco P, et al. Male genitourinary infections by Corynebacterium glucuronolyticum. A review and clinical experience. Rev EspQuimioter. 2019;32(5):479–484.
   Web of Science ®Google Scholar
• Sokol-Leszczynska B, Leszczynski P, Lachowicz D, et al. Corynebacterium coyleae as potential urinary tract pathogen. Eur J Clin Microbiol Infect Dis. 2019;38(7):1339–1342. doi:10.1007/s10096-019-03565-4
   Web of Science ®Google Scholar
• Gupta R, Popli T, Ranchal P, et al. Corynebacterium Jeikeium endocarditis: a review of the literature. Cardiol Rev. 2021;29(5):259–262. doi:10.1097/CRD.0000000000000355
   Web of Science ®Google Scholar
• Costales J, Alsyouf M, Napolitan P, et al. Corynebacterium urealyticum: rare urinary tract infection with serious complications. Can J Urol. 2019;26(1):9680–9682.
   Web of Science ®Google Scholar
• Hoefer A, Pampaka D, Herrera-Leon S, et al. Molecular and epidemiological characterization of toxigenic and nontoxigenic Corynebacterium diphtheriae, Corynebacterium belfantii, Corynebacterium rouxii, and Corynebacterium ulcerans isolates identified in Spain from 2014 to 2019. J Clin Microbiol. 2021;59(3). doi:10.1128/JCM.02410-20
   Web of Science ®Google Scholar
• Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163–175. doi:10.1038/nprot.2007.521chap
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria CLSI Document M45. 3rd ed. Wayne: CLSI; 2015.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Alibi S, Ferjani A, Boukadida J, et al. Occurrence of Corynebacterium striatum as an emerging antibiotic-resistant nosocomial pathogen in a Tunisian hospital. Sci Rep. 2017;7(1):9704. doi:10.1038/s41598-017-10081-y
   PubMed Web of Science ®Google Scholar
• Chapartegui-Gonzalez I, Fernandez-Martinez M, Rodriguez-Fernandez A, et al. Antimicrobial susceptibility and characterization of resistance mechanisms of Corynebacterium urealyticum clinical isolates. Antibiotics. 2020;9(7):404. doi:10.3390/antibiotics9070404
   Web of Science ®Google Scholar
• Ramos JN, Valadao TB, Baio P, et al. Novel mutations in the QRDR region gyrA gene in multidrug-resistance Corynebacterium spp. isolates from intravenous sites. Antonie Van Leeuwenhoek. 2020;113(4):589–592. doi:10.1007/s10482-019-01353-w
   Web of Science ®Google Scholar
• Ramos JN, Souza C, Faria YV, et al. Bloodstream and catheter-related infections due to different clones of multidrug-resistant and biofilm producer Corynebacterium striatum. BMC Infect Dis. 2019;19(1):672. doi:10.1186/s12879-019-4294-7
   Web of Science ®Google Scholar
• Souza C, Faria YV, Sant’Anna LO, et al. Biofilm production by multiresistant Corynebacterium striatum associated with nosocomial outbreak. Mem Inst Oswaldo Cruz. 2015;110(2):242–248. doi:10.1590/0074-02760140373
   PubMed Web of Science ®Google Scholar
• Yoon S, Kim H, Lee Y, et al. Bacteremia caused by Corynebacterium amycolatum with a novel mutation in gyrA gene that confers high-level quinolone resistance. Korean J Lab Med. 2011;31(1):47–48. doi:10.3343/kjlm.2011.31.1.47
   Google Scholar
• Wang Y, Shi X, Zhang J, et al. Wide spread and diversity of mutation in the gyrA gene of quinolone-resistant Corynebacterium striatum strains isolated from three tertiary hospitals in China. Ann Clin Microbiol Antimicrob. 2021;20(1):71. doi:10.1186/s12941-021-00477-0
   Web of Science ®Google Scholar
• Zaw MT, Emran NA, Lin Z. Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis. J Infect Public Health. 2018;11(5):605–610. doi:10.1016/j.jiph.2018.04.005
   PubMed Web of Science ®Google Scholar
• Osio A. Corynebacterium-associated skin infections. Ann Dermatol Venereol. 2018;145(3):214–218. doi:10.1016/j.annder.2018.01.039
   Web of Science ®Google Scholar
• Rocha D, Azevedo V, Brenig B, et al. Whole-genome sequencing reveals misidentification of a multidrug-resistant urine clinical isolate as Corynebacterium urealyticum. J Glob Antimicrob Resist. 2020;23:16–19. doi:10.1016/j.jgar.2020.07.020
   Web of Science ®Google Scholar
• Salem N, Salem L, Saber S, et al. Corynebacterium urealyticum: a comprehensive review of an understated organism. Infect Drug Resist. 2015;8:129–145. doi:10.2147/IDR.S74795
   PubMed Web of Science ®Google Scholar
• Leyton B, Ramos JN, Baio P, et al. Treat me well or will resist: uptake of mobile genetic elements determine the resistome of Corynebacterium striatum. Int J Mol Sci. 2021;22(14):7499. doi:10.3390/ijms22147499
   Web of Science ®Google Scholar
• Shariff M, Aditi A, Beri K. Corynebacterium striatum: an emerging respiratory pathogen. J Infect Dev Ctries. 2018;12(7):581–586. doi:10.3855/jidc.10406
   PubMed Web of Science ®Google Scholar
• Sutcliffe J, Grebe T, Tait-Kamradt A, et al. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother. 1996;40(11):2562–2566. doi:10.1128/AAC.40.11.2562
   PubMed Web of Science ®Google Scholar
• Galimand M, Fishovitz J, Lambert T, et al. AAC(3)-XI, a new aminoglycoside 3-N-acetyltransferase from Corynebacterium striatum. Antimicrob Agents Chemother. 2015;59(9):5647–5653. doi:10.1128/AAC.01203-15
   Web of Science ®Google Scholar
• Farrell K, Tandan M, Hernandez SV, et al. Treatment of uncomplicated UTI in males: a systematic review of the literature. BJGP Open. 2021;5(2):bjgpopen20X101140. doi:10.3399/bjgpopen20X101140
   PubMedGoogle Scholar
• Mohamed AH, Sheikh ON, Osman MM, et al. Antimicrobial resistance and predisposing factors associated with catheter-associated UTI caused by uropathogens exhibiting multidrug-resistant patterns: a 3-year retrospective study at a Tertiary Hospital in Mogadishu, Somalia. Trop Med Infect Dis. 2022;7(3). doi:10.3390/tropicalmed7030042
   Google Scholar
• Noussair L, Salomon E, El SF, et al. Monomicrobial bone and joint infection due to Corynebacterium striatum: literature review and amoxicillin-rifampin combination as treatment perspective. Eur J Clin Microbiol Infect Dis. 2019;38(7):1269–1278. doi:10.1007/s10096-019-03542-x
   Web of Science ®Google Scholar
• Shah M, Murillo JL. Successful treatment of Corynebacterium striatum endocarditis with daptomycin plus rifampin. Ann Pharmacother. 2005;39(10):1741–1744. doi:10.1345/aph.1G242
   Web of Science ®Google Scholar
• Soriano F, Tauch A. Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone. Clin Microbiol Infect. 2008;14(7):632–643. doi:10.1111/j.1469-0691.2008.02023.x
   PubMed Web of Science ®Google Scholar
• Lansalot-Matras P, Dubourdieu B, Bosc R, et al. Encrusted cystitis by Corynebacterium urealyticum. Med Mal Infect. 2017;47(2):167–170. doi:10.1016/j.medmal.2016.11.004
   Web of Science ®Google Scholar
• Lopez-Gonzalez GJ, de Gracia GM, Navarro-Mari JM, et al. Corynebacterium jeikeium urinary tract infection and good clinical response with nitrofurantoin treatment. Rev EspQuimioter. 2019;32(1):89–90.
   Web of Science ®Google Scholar